Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Narkosen Stockholm AB
AB
Dissolved
Org 5594067513
Medical specialists activities
· NACE 8622
Est. 2022
0 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Narkosen Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
518
69
Staff expenses
−7
−5
EBITDA
386
−28
Depreciation & amort.
—
—
EBIT
386
−28
Net financials
4
5
Profit before tax
293
74
Tax
−60
−16
Net profit
232
58
Balance sheet
SEK thousands
Item
2023
2024
Total assets
435
260
Equity
257
165
Long-term debt
—
—
Short-term debt
81
94
Total debt
81
94
Financial ratios
5-year trend
EBITDA margin
-40.7%
This company
15.8%
Market median
-358% vs market
2023
2024
Equity ratio
63.7%
This company
38.2%
Market median
+67% vs market
2023
2024
Return on equity
35.1%
This company
18.4%
Market median
+91% vs market
2023
2024
Net profit margin
84.8%
This company
8.1%
Market median
+947% vs market
2023
2024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
2023
2024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-11-18 – 2023-12-31
View
PDF
More on Narkosen Stockholm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot